{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"43","upperLimit":"82","value":"51"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"86"}],"units":"Participants"}],"description":"Time to first response is the duartion of time required to achieve first response to treatment","dispersionType":"95% Confidence Interval","groups":[{"description":"JNJ-26866138 1.3 mg/m2 on Days 1, 8, 22 and 29 of 6-week cycle for 5-9 cycles. Melphalan 9 mg/m2 and Prednisolone 60 mg/m2 on Days 1, 2, 3 and 4 of 6-week cycle up to 9 cycles","id":"OG000","title":"Phase II - JNJ-26866138 1.3 mg/m2 Group"}],"paramType":"MEDIAN","populationDescription":"Full analysis set: All participants who received at least one dose of the study medication.","reportingStatus":"POSTED","timeFrame":"up to 54 weeks","title":"Median Time to First Response - Phase II","type":"SECONDARY","unitOfMeasure":"Days"}